
Syed K. Hasan
@SyedKHasan1
Followers
313
Following
306
Media
5
Statuses
170
Associate Professor (Translational Research), PI Hasan Lab ACTREC Tata Memorial Centre Mumbai India. https://t.co/auOGPDy3KE
Joined August 2018
RT @aiims_newdelhi: Cases of Acute Myeloid Leukaemia (AML) - a rare, fast-growing cancer of the blood and bone marrow - are rising in the 3….
0
205
0
RT @Kutub_joy: Historical.#Personalized_Gene_Editing to Treat an Inborn Error of Metabolism.Disease causing DNA letter was corrected to a h….
0
6
0
RT @DrGauravNarula: 2012 a friend said- “Science Fiction”.2015 we dared to dream.Sharing 🇮🇳 1st novel #CARTCellRx Ph 1/1b trial.We report 9….
0
39
0
Sunday reading with your coffee! @ACTREC_TMC @CRI_ACTREC @SocietyofHemOnc @EHA_Hematology @BloodAdvances
17
30
116
RT @CRI_ACTREC: Full version article out now!! .Congratulations @SyedKHasan1.Lab and @maityakash48.@biopatrika @ACTREC_TMC.@BloodAdvances.h….
0
6
0
RT @Hema_News: Led by Drs. Jayastu Senapati (@jayastuMD) and Naval Daver (@Daver_Leukemia), this retrospective analysis in @Haematologica i….
0
4
0
RT @Chaudhary9Nazia: I'm thrilled to announce that my paper in redox biology is finally out! This milestone marks my first solo correspondi….
0
9
0
RT @maityakash48: (2) We developed CRISPR-Cas12 assay to detect PML-RARA isoforms on a lateral flow strip with ultimate goal of achieving e….
0
1
0
Huge congratulations to my amazing student-friends for their outstanding work! CRISPR-Cas system is set to revolutionize cancer diagnostics. Proud of this brilliant team! @ACTREC_TMC @AML_Hub @BloodAdvances @BloodJournal @CRI_ACTREC @TataMemorial.
(2) We developed CRISPR-Cas12 assay to detect PML-RARA isoforms on a lateral flow strip with ultimate goal of achieving equipment-free acute promyelocytic leukemia diagnosis suitable for OPD settings. Article:
7
8
33
Huge thanks to @AurigeneDiscov and @MuraliRamachan5.
Many congratulations and very proud of you @Gaur_tarang on winning soho young investigator fellowship at prestigious @SocietyofHemOnc excellent work which is going soon in clinics. hope you will return to contribute to indian science again. @CRI_ACTREC
0
1
4
Many congratulations and very proud of you @Gaur_tarang on winning soho young investigator fellowship at prestigious @SocietyofHemOnc excellent work which is going soon in clinics. hope you will return to contribute to indian science again. @CRI_ACTREC
1
3
21
This is an amazing piece of work in a very prestigious journal. Many congratulations to all of you.
Congratulations to the brilliant PhD student, @MadhuraKetkar for this excellent study identifying molecular switch for TIS reversal in GBM. Paper's now online @NeuroOnc. Thank you co-authors, @DBTIndia, @serbonline, @ACTREC_TMC, @CRI_ACTREC for support.
0
0
5
RT @Deepshikha_Dia: Presenting #poster at #EHA2024 and receiving prestigious #travel_grant_award is one of the best opportunities in my Ph.….
0
3
0
RT @maityakash48: Feeling deeply grateful for this proud moment! Thank you @SyedKHasan1 Sir for the opportunity to witness and learn such g….
0
1
0
Congratulations, @maityakash48! What a proud moment seeing your 3rd-year PhD student present single-cell sequencing data on acute promyelocytic leukemia at a prestigious international meeting on APL. 🌟 #ResearchExcellence #ProudMentor @CRI_ACTREC @ACTREC_TMC @prantar @bagalbp
8
1
42
RT @Gaur_tarang: Extremely happy to complete my doctorate!!!! Immense love for my lab members and my mentor @SyedKHasan1 . It was pleasure….
0
4
0
RT @QUBBloodCancer: Another #PhD success with news that @Gaur_tarang based in @ACTREC_TMC #Mumbai with @SyedKHasan1 has passed her #viva.….
0
2
0
RT @CRI_ACTREC: Upcoming PhD intake 2024 @CRI_ACTREC.@ACTREC_TMC Candidates who have qualified CSIR/DBT/ICMR/UGC can now apply for interv….
0
4
0
Many congratulations to you and Saket. Fantastic work. @DuttShilpee.
Excited to share our paper on transcriptional regulation of Top2b by DNA-PKcs in AML. Out in @J_Cell_Sci Congratulations @svm2607 the lead author & co-authors @debashmitasark5 @SyedKHasan1 @Archisman_bnj. Thanks @DBTIndia @DAEIndia @ACTREC_TMC for funding
1
0
7